MIT Corporation life member and biotech pioneer Henri Termeer dies at 71
Termeer built Genzyme from a startup into a biotech powerhouse, while becoming an innovator in rare-disease drug development.
Termeer built Genzyme from a startup into a biotech powerhouse, while becoming an innovator in rare-disease drug development.
Study at MIT Medical finds most parents are capable of performing the test.
Introducing genetic mutations with CRISPR offers a fast and accurate way to simulate the disease.
Hadley Sikes is bridging the gap between engineering and public policy to solve big social problems at home and abroad.
Differences in chromosome number may underlie variation among genetically identical individuals.
Specialized droplets interact with bacteria and can be analyzed using a smartphone.
Beckman Foundation grant helps secure cryo-electron microscopy at MIT.nano facility.
New research shows large spillover from the lab to commercial activity.
Researchers program RNA nanoparticles that could protect against the virus.
New technique can reveal exposure to aflatoxin, a potent carcinogen, before tumors develop.
Asian flu strains can enter North America through Alaska, study finds.
Global precipitation may account for 1 to 25 percent of bacteria emitted from land.
Study finds a role for randomness in the composition of the gut’s microbe populations.
New sensor could reveal the neurotransmitter’s role in learning and habit formation.
Measuring the parasite’s heme levels could help scientists develop better antimalarial drugs.